CereVasc is a medical device company developing the eShunt® System for the treatment of Normal Pressure Hydrocephalus (NPH).
The company focuses on advancing a minimally invasive neurosurgical implant through pivotal clinical trials and regulatory activities toward FDA Premarket Approval and U.S. commercialization.